Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) Given Average Recommendation of “Reduce” by Analysts

Shares of Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) have been assigned a consensus rating of “Reduce” from the six research firms that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation and four have issued a hold recommendation on the company.

A number of research firms have recently weighed in on BDRFF. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Beiersdorf Aktiengesellschaft in a research note on Wednesday, March 18th. Berenberg Bank reaffirmed a “hold” rating on shares of Beiersdorf Aktiengesellschaft in a research note on Monday, March 23rd. Morgan Stanley downgraded shares of Beiersdorf Aktiengesellschaft from an “equal weight” rating to an “underweight” rating in a research note on Monday, March 16th. Royal Bank Of Canada downgraded shares of Beiersdorf Aktiengesellschaft from a “sector perform” rating to an “underperform” rating in a research note on Tuesday, March 10th. Finally, UBS Group raised shares of Beiersdorf Aktiengesellschaft from a “sell” rating to a “neutral” rating in a research note on Tuesday, March 31st.

Beiersdorf Aktiengesellschaft Price Performance

OTCMKTS:BDRFF opened at $82.22 on Wednesday. Beiersdorf Aktiengesellschaft has a fifty-two week low of $81.25 and a fifty-two week high of $135.52. The business has a 50 day moving average price of $86.66 and a 200-day moving average price of $101.39.

About Beiersdorf Aktiengesellschaft

Beiersdorf Aktiengesellschaft is a global consumer goods company headquartered in Hamburg, Germany, with a history dating back to its founding in 1882 by pharmacist Paul C. Beiersdorf. The company is best known for its skincare brands, including NIVEA, Eucerin, La Prairie and Labello, as well as its tesa division, which produces self-adhesive products and industrial tapes. Over its long history, Beiersdorf has built a reputation for innovation in dermatological research and product development, introducing pioneering formulations that span mass-market and premium segments.

The company’s operations are organized into two main business divisions.